-
Loading metrics
Open Access
Peer-reviewed
Research Article
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
-
Sara Stinca ,
Contributed equally to this work with: Sara Stinca, Thomas W. Barnes
Roles Data curation, Formal analysis, Methodology, Project administration, Visualization
Affiliation Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
⨯ -
Thomas W. Barnes ,
Contributed equally to this work with: Sara Stinca, Thomas W. Barnes
Roles Data curation, Formal analysis, Methodology, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
⨯ -
Peter Vogel,
Roles Formal analysis, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing
Affiliation Global Digital Core, Plasma Product Development, Research & Development, CSL Behring Innovation GmbH, Marburg, Germany
⨯ -
Wilfried Meyers,
Roles Formal analysis, Methodology, Writing – review & editing
Affiliation Global Digital Core, Plasma Product Development, Research & Development, CSL Behring Innovation GmbH, Marburg, Germany
⨯ -
Johannes Schulte-Pelkum,
Roles Data curation, Formal analysis, Investigation, Methodology
Affiliation Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Freiburg, Germany
⨯ -
Daniel Filchtinski,
Roles Investigation, Methodology
Affiliation Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Freiburg, Germany
⨯ -
Laura Steller,
Roles Investigation, Methodology
Affiliation Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Freiburg, Germany
⨯ -
Thomas Hauser,
Roles Investigation, Methodology, Visualization
Affiliation Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
⨯ -
Sandro Manni,
Roles Writing – review & editing
Affiliation Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
⨯ -
David F. Gardiner,
Roles Writing – original draft
Affiliation Immunology, CSL Behring, King of Prussia, Pennsylvania, United States of America
⨯ -
Sharon Popik,
Roles Writing – review & editing
Affiliation Immunology, CSL Behring, King of Prussia, Pennsylvania, United States of America
⨯ -
Nathan J. Roth,
Roles Conceptualization, Resources, Supervision
Affiliation Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
⨯ -
Patrick Schuetz
Roles Conceptualization, Resources, Supervision
* E-mail: Patrick.Schuetz@cslbehring.com
Affiliation Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
⨯
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
- Sara Stinca,
- Thomas W. Barnes,
- Peter Vogel,
- Wilfried Meyers,
- Johannes Schulte-Pelkum,
- Daniel Filchtinski,
- Laura Steller,
- Thomas Hauser,
- Sandro Manni,
- David F. Gardiner
- Published: November 29, 2021
- https://doi.org/10.1371/journal.pone.0259731